Skip to content
10-Q

Quarterly Report

Harpoon Therapeutics, Inc.

0000950170-23-062125

← back to feed
Filed
Nov 9, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Oct 31, 2023 16.93M sh
Shares Diluted Q3 2023 · Sep 30, 2023 3.95M sh
Shares Diluted Q3 2023 · Sep 30, 2023 3.81M sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 3.31M sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 3.3M sh
Capex Q3 2023 · Sep 30, 2023 $91K
Capex Q3 2023 · Sep 30, 2022 $319K
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$50.99M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$70.79M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $17.74M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $51.61M
Stockholders Equity Q3 2023 · Sep 30, 2023 $4.54M
Stockholders Equity Q3 2023 · Jun 30, 2023 $3M
Stockholders Equity Q3 2023 · Mar 31, 2023 $696K
Stockholders Equity Q3 2023 · Dec 31, 2022 $5.4M
Stockholders Equity Q3 2023 · Sep 30, 2022 $16.91M
Stockholders Equity Q3 2023 · Jun 30, 2022 $26.64M
Stockholders Equity Q3 2023 · Mar 31, 2022 $41.38M
Stockholders Equity Q3 2023 · Dec 31, 2021 $58.07M
Current Liabilities Q3 2023 · Sep 30, 2023 $18.11M
Current Liabilities Q3 2023 · Dec 31, 2022 $52.43M
Total Liabilities Q3 2023 · Sep 30, 2023 $43.04M
Total Liabilities Q3 2023 · Dec 31, 2022 $68.33M
Current Assets Q3 2023 · Sep 30, 2023 $34.3M
Current Assets Q3 2023 · Dec 31, 2022 $54.73M
Total Assets Q3 2023 · Sep 30, 2023 $47.58M
Total Assets Q3 2023 · Dec 31, 2022 $73.73M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.46
Eps Diluted Q3 2023 · Sep 30, 2023 −$3.17
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$3.52
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$14.95
Eps Basic Q3 2023 · Sep 30, 2023 −$0.46
Eps Basic Q3 2023 · Sep 30, 2023 −$3.17
Eps Basic restated Q3 2023 · Sep 30, 2022 −$3.52
Eps Basic restated Q3 2023 · Sep 30, 2022 −$14.95
Sga Expense Q3 2023 · Sep 30, 2023 $4.26M
Sga Expense Q3 2023 · Sep 30, 2023 $12.25M
Sga Expense Q3 2023 · Sep 30, 2022 $4.53M
Sga Expense Q3 2023 · Sep 30, 2022 $14.99M
Rd Expense Q3 2023 · Sep 30, 2023 $12.33M
Rd Expense Q3 2023 · Sep 30, 2023 $39.68M
Rd Expense Q3 2023 · Sep 30, 2022 $20.98M
Rd Expense Q3 2023 · Sep 30, 2022 $62.45M
Net Income Q3 2023 · Sep 30, 2023 −$1.8M
Net Income Q3 2023 · Sep 30, 2023 −$12.08M
Net Income Q3 2023 · Jun 30, 2023 $1.06M
Net Income Q3 2023 · Mar 31, 2023 −$11.34M
Net Income Q3 2023 · Sep 30, 2022 −$11.64M
Net Income Q3 2023 · Sep 30, 2022 −$49.31M
Net Income Q3 2023 · Jun 30, 2022 −$17.35M
Net Income Q3 2023 · Mar 31, 2022 −$20.32M
Operating Income Q3 2023 · Sep 30, 2023 −$12.14M
Operating Income Q3 2023 · Sep 30, 2023 −$20.41M
Operating Income Q3 2023 · Sep 30, 2022 −$11.89M
Operating Income Q3 2023 · Sep 30, 2022 −$49.61M
Revenue Q3 2023 · Sep 30, 2023 $4.45M
Revenue Q3 2023 · Sep 30, 2023 $33.25M
Revenue Q3 2023 · Sep 30, 2022 $13.62M
Revenue Q3 2023 · Sep 30, 2022 $27.83M